Hot Investor Mandate 17: Canada-Based Institutional Alternative Investor Seeks Later-Stage Life Science Investment Opportunities

4 Jan

An institutional alternative investor with several offices in Canada currently manages two venture funds: one fund is $100M in size and was raised in 2016, and the other fund is $300M in size and was raised in 2014. The firm prefers investing in companies that are on the market, but is willing to look at companies that are late into development and about to emerge onto the market.

The firm is agnostic towards their investments into the life sciences field for all their funds. With the first fund, the firm is looking to invest in companies in the British Columbia area which the firm believes can help grow the area. This first fund invests across four major technology sectors: Life sciences, CleanTech, Digital media and Information/Communications Technology. For the firm’s other larger venture fund, the firm is instead looking at more global markets and seeks to invest in companies that seem promising to them. Previous investments by the firm have been more involved in the technology sector.

The firm looks for experienced management teams. For the first fund, the firm cannot lead an investment, but prefers a board seat when investing. For the other fund, the firm is more flexible with leading, but still prefers a board seat when investing.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: